Literature DB >> 21903752

Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation.

Ali Abdul Lattif1, Pranab K Mukherjee1, Jyotsna Chandra1, Mary R Roth2, Ruth Welti2, Mahmoud Rouabhia3, Mahmoud A Ghannoum1.   

Abstract

Candida albicans-associated bloodstream infections are linked to the ability of this yeast to form biofilms. In this study, we used lipidomics to compare the lipid profiles of C. albicans biofilms and planktonic cells, in early and mature developmental phases. Our results showed that significant differences exist in lipid composition in both developmental phases. Biofilms contained higher levels of phospholipid and sphingolipids than planktonic cells (nmol per g biomass, P<0.05 for all comparisons). In the early phase, levels of lipid in most classes were significantly higher in biofilms compared to planktonic cells (P≤0.05). The ratio of phosphatidylcholine to phosphatidylethanolamine was lower in biofilms compared to planktonic cells in both early (1.17 vs 2.52, P≤0.001) and late (2.34 vs 3.81, P≤0.001) developmental phases. The unsaturation index of phospholipids decreased with time, with this effect being particularly strong for biofilms. Inhibition of the biosynthetic pathway for sphingolipid [mannosyl diinositolphosphoryl ceramide, M(IP)₂C] by myriocin or aureobasidin A, and disruption of the gene encoding inositolphosphotransferase (Ipt1p), abrogated the ability of C. albicans to form biofilms. The differences in lipid profiles between biofilms and planktonic Candida cells may have important implications for the biology and antifungal resistance of biofilms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903752      PMCID: PMC3352276          DOI: 10.1099/mic.0.051086-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  36 in total

1.  A gene encoding a sphingolipid biosynthesis enzyme determines the sensitivity of Saccharomyces cerevisiae to an antifungal plant defensin from dahlia (Dahlia merckii).

Authors:  K Thevissen; B P Cammue; K Lemaire; J Winderickx; R C Dickson; R L Lester; K K Ferket; F Van Even; A H Parret; W F Broekaert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Variation in lipid and sterol contents in Candida albicans white and opaque phenotypes.

Authors:  M A Ghannoum; I Swairjo; D R Soll
Journal:  J Med Vet Mycol       Date:  1990

3.  Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.

Authors:  Paul A Aeed; Casey L Young; Marek M Nagiec; Ake P Elhammer
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

4.  The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans.

Authors:  C A Hitchcock; K J Barrett-Bee; N J Russell
Journal:  J Gen Microbiol       Date:  1986-09

5.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  Temporal analysis of Candida albicans gene expression during biofilm development.

Authors:  Kathleen M Yeater; Jyotsna Chandra; Georgina Cheng; Pranab K Mukherjee; Xiaomin Zhao; Sandra L Rodriguez-Zas; Kurt E Kwast; Mahmoud A Ghannoum; Lois L Hoyer
Journal:  Microbiology (Reading)       Date:  2007-08       Impact factor: 2.777

7.  Lipid raft polarization contributes to hyphal growth in Candida albicans.

Authors:  Stephen W Martin; James B Konopka
Journal:  Eukaryot Cell       Date:  2004-06

8.  Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells.

Authors:  M A Ghannoum; G R Burns; K A Elteen; S S Radwan
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

9.  Differences in amino acid transport and phospholipid contents during the cell cycle of Candida albicans.

Authors:  A K Dudani; R Prasad
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

10.  Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts.

Authors:  Ritu Pasrija; Sneh Lata Panwar; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

View more
  37 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

2.  Characterization of a lysophospholipid acyltransferase involved in membrane remodeling in Candida albicans.

Authors:  Mariam Ayyash; Amal Algahmi; John Gillespie; Peter Oelkers
Journal:  Biochim Biophys Acta       Date:  2014-01-07

3.  Candida albicans fatty acyl-CoA synthetase, CaFaa4p, is involved in the uptake of exogenous long-chain fatty acids and cell activity in the biofilm.

Authors:  Kengo Tejima; Masanori Ishiai; Somay O Murayama; Shun Iwatani; Susumu Kajiwara
Journal:  Curr Genet       Date:  2017-09-23       Impact factor: 3.886

4.  Lipidomics characterization of the alterations of Trichoderma brevicompactum membrane glycerophospholipids during the fermentation phase.

Authors:  Yunfan Bai; Yuran Gao; Xin Lu; Huiyu Wang
Journal:  J Ind Microbiol Biotechnol       Date:  2019-03-07       Impact factor: 3.346

Review 5.  Functional diversity of complex I subunits in Candida albicans mitochondria.

Authors:  Dongmei Li; Xiaodong She; Richard Calderone
Journal:  Curr Genet       Date:  2015-09-15       Impact factor: 3.886

6.  Genetically Compromising Phospholipid Metabolism Limits Candida albicans' Virulence.

Authors:  Dorothy Wong; James Plumb; Hosamiddine Talab; Mouhamad Kurdi; Keshav Pokhrel; Peter Oelkers
Journal:  Mycopathologia       Date:  2019-01-28       Impact factor: 2.574

7.  A detailed lipidomic study of human pathogenic fungi Candida auris.

Authors:  Garima Shahi; Mohit Kumar; Sonam Kumari; Shivaprakash M Rudramurthy; Arunaloke Chakrabarti; Naseem A Gaur; Ashutosh Singh; Rajendra Prasad
Journal:  FEMS Yeast Res       Date:  2020-09-01       Impact factor: 2.796

Review 8.  Sphingolipids as targets for treatment of fungal infections.

Authors:  Rodrigo Rollin-Pinheiro; Ashutosh Singh; Eliana Barreto-Bergter; Maurizio Del Poeta
Journal:  Future Med Chem       Date:  2016-08-09       Impact factor: 3.808

Review 9.  Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies.

Authors:  Caroline Mota Fernandes; Maurizio Del Poeta
Journal:  Expert Rev Anti Infect Ther       Date:  2020-07-16       Impact factor: 5.091

Review 10.  Plasma membrane lipids and their role in fungal virulence.

Authors:  Antonella Rella; Amir M Farnoud; Maurizio Del Poeta
Journal:  Prog Lipid Res       Date:  2015-12-15       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.